Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wagner

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
JCI Insight|July 21, 2017
Hepatic JAK2 protects against atherosclerosis through circulating IGF-1Tharini Sivasubramaniyam, Stephanie A Schroer, Angela Li, et al.
Journal of Medical Systems|July 4, 2026
AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose systemJonas Freudenberg, Johannes Knitza, Niklas Gremke, et al.
Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCGJacobus Pfisterer, Marie Plante, Ignace Vergote, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
The Journal of Biological Chemistry|August 18, 2025
Platelet Jak2-deficiency accelerates atherosclerosis with increased inflammatory responseDaeun Kim, Yu Zhe Li, Jiaqi Yang, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2008
2008 update of the guideline: early detection of breast cancer in GermanyUte-Susann Albert, Helmut Altland, Volker Duda, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
International Journal of Surgery (London, England)|February 24, 2025
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysisFabian Trillsch, Bastian Czogalla, Sven Mahner, et al.
JCI Insight|July 21, 2017
Hepatic JAK2 protects against atherosclerosis through circulating IGF-1Tharini Sivasubramaniyam, Stephanie A Schroer, Angela Li, et al.
Journal of Medical Systems|July 4, 2026
AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose systemJonas Freudenberg, Johannes Knitza, Niklas Gremke, et al.
Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCGJacobus Pfisterer, Marie Plante, Ignace Vergote, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
The Journal of Biological Chemistry|August 18, 2025
Platelet Jak2-deficiency accelerates atherosclerosis with increased inflammatory responseDaeun Kim, Yu Zhe Li, Jiaqi Yang, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2008
2008 update of the guideline: early detection of breast cancer in GermanyUte-Susann Albert, Helmut Altland, Volker Duda, et al.
Molecular Cancer Therapeutics|July 13, 2021
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to EverolimusGabriel B Mpilla, Md Hafiz Uddin, Mohammed N Al-Hallak, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Pageof 21